Postgraduate Medicine
Volume 133, 2021 - Issue 4
Clinical features - Original research
Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder
Fulton F. Veleza Medical Affairs, Research and Development, Pear Therapeutics, Inc, Boston, MA, United StatesCorrespondence[email protected]
https://orcid.org/0000-0001-9054-5933View further author information
https://orcid.org/0000-0001-9054-5933View further author information, , , Benjamin Parcherb Formerly with Xcenda, LLC., Palm Harbor, FL, United Stateshttps://orcid.org/0000-0002-5673-7007View further author information
https://orcid.org/0000-0002-5673-7007View further author information, & Daniel C. Malonec Strategic Therapeutics, LLC., Oro Valley, AZ, United Stateshttps://orcid.org/0000-0002-5006-9394View further author information
https://orcid.org/0000-0002-5006-9394View further author information